LALPATHLAB2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member LALPATHLAB2022-01-012022-03-31in-bse-fin:OneOperatingExpenses02Member LALPATHLAB2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member LALPATHLAB2022-01-012022-03-31in-bse-fin:FourOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LALPATHLAB 2021-04-01 2022-03-31 2022-05-06 INR Millions Yearly true Cash Flow Indirect Single segment The business of running laboratories for carrying out Pathological investigations of various branches of Bio-chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Immuno-chemistry, Immunology, Virology, Cytology, other pathological and radiological investigations. 2022-01-01 2022-03-31 Unaudited Standalone 4149000000.00 129000000.00 4278000000.00 913000000.00 0.00 0.00 802000000.00 111000000.00 215000000.00 1386000000.00 3427000000.00 851000000.00 0.00 851000000.00 172000000.00 27000000.00 199000000.00 0.00 652000000.00 0.00 0.00 0.00 0.00 652000000.00 19000000.00 671000000.00 0.00 0.00 833000000.00 10 7.88 7.85 0.00 0.00 7.88 7.85 i. The above results were reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 17 May, 2022. The financial results for the year ended 31 March, 2022 have been audited and for the quarter ended 31 March, 2022 have been reviewed by the statutory auditors of the Company and they have issued an unmodified report thereon. ii. These financial results of the Company have been prepared in accordance with the Indian Accounting Standards (Ind AS) as notified by Ministry of Corporate Affairs pursuant to Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and other accounting principles generally accepted in India. iii. Figures for the quarter ended 31 March, 2022 and 31 March, 2021 are the balancing figures between the audited figures in respect of full financial year and the published year to date unaudited figures up to the third quarter ended 31 December, 2021 and 31 December, 2020 respectively, which was subjected to limited review. iv. During the year ended 31 March, 2022 , the Company has made a further investment of INR 45 million in its wholly owned subsidiary, PathLabs Unifiers Private Limited, through subscription of additional equity shares. v. During the year ended 31 March, 2021, the Company has made a further investment of INR 1 million (KES 1.48 million) in its wholly owned subsidiary, Dr. Lal PathLabs Kenya Private Limited, through subscription of additional equity shares. Due to size constraint, we have not pasted complete note to statement of financial results. Please refer pdf file for complete notes to the statement of Financial Results for the quarter and year ended March 31, 2022. Single segment 2021-04-01 2022-03-31 Audited Standalone 18727000000.00 530000000.00 19257000000.00 4463000000.00 0.00 0.00 3202000000.00 285000000.00 753000000.00 5960000000.00 14663000000.00 4594000000.00 0.00 4594000000.00 1180000000.00 -27000000.00 1153000000.00 0.00 3441000000.00 0.00 0.00 0.00 0.00 3441000000.00 -13000000.00 3428000000.00 0.00 0.00 833000000.00 10 13931000000.00 41.61 41.48 0.00 0.00 41.61 41.48 Fees to collection centers/channel partners 619000000.00 Other expenses 767000000.00 Fees to collection centers/channel partners 2737000000.00 Other expenses 3223000000.00 285000000.00 -8000000.00 -2000000.00 0.00 -46000000.00 0.00 0.00 -30000000.00 0.00 -122000000.00 0.00 70000000.00 0.00 753000000.00 11000000.00 45000000.00 0.00 37000000.00 0.00 0.00 16000000.00 448000000.00 315000000.00 0.00 0.00 0.00 -20000000.00 -9000000.00 0.00 815000000.00 5409000000.00 0.00 0.00 0.00 1171000000.00 0.00 4238000000.00 0.00 9417000000.00 3684000000.00 3161000000.00 0.00 0.00 0.00 0.00 4000000.00 631000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 55000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 16000000.00 478000000.00 0.00 4597000000.00 0.00 -4485000000.00 0.00 0.00 0.00 0.00 0.00 0.00 1000000.00 0.00 3454000000.00 0.00 0.00 593000000.00 1157000000.00 285000000.00 0.00 0.00 1420000000.00 1173000000.00 0.00 1173000000.00 2317000000.00 3490000000.00